Preconditioning with physiological levels of ethanol protect kidney against ischemia/reperfusion injury by modulating oxidative stress

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Yuan, Qing ^a,c   Hong, Shanjuan ^b   Han, Shu ^a   Zeng, Li ^a   Liu, Fang ^a   Ding, Guoshan ^a   Kang, Yindong ^a   Mao, Jingyan ^b   Cai, Ming ^c   Zhu, Youhua ^a   Wang, Quan Xing ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c 309TH HOSPITAL OF PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ALCOHOL; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; MALONALDEHYDE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; ALDEHYDE DEHYDROGENASE 2, MOUSE; PROTECTIVE AGENT;

ALCOHOL BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; C57BL 6 MOUSE; CYTOKINE PRODUCTION; DETOXIFICATION; ENZYME ACTIVITY; HISTOPATHOLOGY; INFLAMMATION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE DAMAGE; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROPHYLAXIS; RENAL PROTECTION; REPERFUSION INJURY; SINGLE DRUG DOSE; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECT; ENZYMOLOGY; GENE SILENCING; ISCHEMIC PRECONDITIONING; KIDNEY; KIDNEY TUBULE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

MUS;

ALDEHYDE DEHYDROGENASE; ANIMALS; ETHANOL; GENE KNOCKDOWN TECHNIQUES; INFLAMMATION; ISCHEMIC PRECONDITIONING; KIDNEY; KIDNEY TUBULES; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PROTECTIVE AGENTS; REPERFUSION INJURY;

EID: 80053958401     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025811     Document Type: Article

References (46)

1. Gelman S, (1995) The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology 82: 1026-1060.
2. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW, (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365-3370.
3. Pomfret EA, Sung RS, Allan J, Kinkhabwala M, Melancon JK, et al. (2008) Solving the organ shortage crisis: the 7th annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. Am J Transplant 8: 745-752.
4. Sheridan AM, Bonventre JV, (2000) Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens 9: 427-434.
5. Bonventre JV, Zuk A, (2004) Ischemic acute renal failure: an inflammatory disease? Kidney Int 66: 480-485.
6. Akcay A, Nguyen Q, Edelstein CL, (2009) Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009: 137072.
7. Kinsey GR, Li L, Okusa MD, (2008) Inflammation in acute kidney injury. Nephron Exp Nephrol 109: e102-107.
8. Hayama T, Matsuyama M, Funao K, Tanaka T, Tsuchida K, et al. (2007) Triggers of inflammation after renal ischemia/reperfusion. Transplant Proc 123: 7-13.
9. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, et al. (2001) Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 281: F948-957.
10. Walker LM, York JL, Imam SZ, Ali SF, Muldrew KL, et al. (2001) Oxidative stress and reactive nitrogen species generation during renal ischemia. Toxicol Sci 63: 143-148.
11. Lloberas N, Torras J, Herrero-Fresneda I, Cruzado JM, Riera M, et al. (2002) Postischemic renal oxidative stress induces inflammatory response through PAF and oxidized phospholipids. Prevention by antioxidant treatment. Faseb J 16: 908-910.
12. Aragno M, Cutrin JC, Mastrocola R, Perrelli MG, Restivo F, et al. (2003) Oxidative stress and kidney dysfunction due to ischemia/reperfusion in rat: attenuation by dehydroepiandrosterone. Kidney Int 64: 836-843.
13. McCord JM, (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159-163.
14. Eschwege P, Paradis V, Conti M, Holstege A, Richet F, et al. (1999) In situ detection of lipid peroxidation by-products as markers of renal ischemia injuries in rat kidneys. J Urol 162: 553-557.
15. Niki E, Yoshida Y, Saito Y, Noguchi N, (2005) Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun 338: 668-676.
16. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, et al. (2008) Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321: 1493-1495.
17. Churchill EN, Disatnik MH, Mochly-Rosen D, (2009) Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2. J Mol Cell Cardiol 46: 278-284.
18. Vasiliou V, Nebert DW, (2005) Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics 2: 138-143.
19. Wang Q, Sun AY, Simonyi A, Kalogeris TJ, Miller DK, et al. (2007) Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS. Free Radic Biol Med 43: 1048-1060.
20. Yamaguchi T, Dayton C, Shigematsu T, Carter P, Yoshikawa T, et al. (2002) Preconditioning with ethanol prevents postischemic leukocyte-endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 283: H1019-1030.
21. Yamaguchi T, Dayton CB, Ross CR, Yoshikawa T, Gute DC, et al. (2003) Late preconditioning by ethanol is initiated via an oxidant-dependent signaling pathway. Free Radic Biol Med 34: 365-376.
22. Wuthrich RP, Glimcher LH, Yui MA, Jevnikar AM, Dumas SE, et al. (1990) MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 37: 783-792.
23. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, et al. (2007) TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117: 2847-2859.
24. Meldrum KK, Meldrum DR, Hile KL, Burnett AL, Harken AH, (2001) A novel model of ischemia in renal tubular cells which closely parallels in vivo injury. J Surg Res 99: 288-293.
25. Kim J, Jang HS, Park KM, (2010) Reactive oxygen species generated by renal ischemia and reperfusion trigger protection against subsequent renal ischemia and reperfusion injury in mice. Am J Physiol Renal Physiol 298: F158-166.
26. Kim KH, Dhupar R, Ueki S, Cardinal J, Pan P, et al. (2009) Donor graft interferon regulatory factor-1 gene transfer worsens liver transplant ischemia/reperfusion injury. Surgery 146: 181-189.
27. Esterbauer H, Koller E, Slee RG, Koster JF, (1986) Possible involvement of the lipid-peroxidation product 4-hydroxynonenal in the formation of fluorescent chromolipids. Biochem J 239: 405-409.
28. Hart ML, Much C, Kohler D, Schittenhelm J, Gorzolla IC, et al. (2008) Use of a hanging-weight system for liver ischemic preconditioning in mice. Am J Physiol Gastrointest Liver Physiol 294: G1431-1440.
29. Budas GR, Disatnik MH, Chen CH, Mochly-Rosen D, Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCvarepsilon) knockout mice. J Mol Cell Cardiol 48: 757-764.
30. Castilla R, Gonzalez R, Fouad D, Fraga E, Muntane J, (2004) Dual effect of ethanol on cell death in primary culture of human and rat hepatocytes. Alcohol Alcohol 39: 290-296.
31. de Labry LO, Glynn RJ, Levenson MR, Hermos JA, LoCastro JS, et al. (1992) Alcohol consumption and mortality in an American male population: recovering the U-shaped curve-findings from the normative Aging Study. J Stud Alcohol 53: 25-32.
32. Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, et al. (1995) Alcohol consumption and mortality among women. N Engl J Med 332: 1245-1250.
33. Gaziano JM, Gaziano TA, Glynn RJ, Sesso HD, Ajani UA, et al. (2000) Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol 35: 96-105.
34. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, et al. (1991) Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 338: 464-468.
35. Pearson TA, (1996) Alcohol and heart disease. Circulation 94: 3023-3025.
36. Presti RL, Carollo C, Caimi G, (2007) Wine consumption and renal diseases: new perspectives. Nutrition 23: 598-602.
37. Cecchin E, De Marchi S, (1996) Alcohol misuse and renal damage. Addict Biol 1: 7-17.
38. Facchini FS, Saylor KL, (2003) A low-iron-available, polyphenol-enriched, carbohydrate-restricted diet to slow progression of diabetic nephropathy. Diabetes 52: 1204-1209.
39. Krajka-Kuzniak V, Baer-Dubowska W, (2003) The effects of tannic acid on cytochrome P450 and phase II enzymes in mouse liver and kidney. Toxicol Lett 143: 209-216.
40. Satyanarayana PS, Singh D, Chopra K, (2001) Quercetin, a bioflavonoid, protects against oxidative stress-related renal dysfunction by cyclosporine in rats. Methods Find Exp Clin Pharmacol 23: 175-181.
41. Li X, Kimura H, Hirota K, Kasuno K, Torii K, et al. (2005) Synergistic effect of hypoxia and TNF-alpha on production of PAI-1 in human proximal renal tubular cells. Kidney Int 68: 569-583.
42. Ishikawa Y, Kitamura M, (2000) Bioflavonoid quercetin inhibits mitosis and apoptosis of glomerular cells in vitro and in vivo. Biochem Biophys Res Commun 279: 629-634.
43. Shigematsu S, Ishida S, Hara M, Takahashi N, Yoshimatsu H, et al. (2003) Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radic Biol Med 34: 810-817.
44. Kahraman A, Erkasap N, Serteser M, Koken T, (2003) Protective effect of quercetin on renal ischemia/reperfusion injury in rats. J Nephrol 16: 219-224.
45. Dayton C, Yamaguchi T, Kamada K, Carter P, Korthuis RJ, (2004) Antecedent ethanol ingestion prevents postischemic P-selectin expression in murine small intestine. Microcirculation 11: 709-718.
46. Kim JI, Jang HS, Park KM, (2010) Endotoxin-induced renal tolerance against ischemia and reperfusion injury is removed by iNOS, but not eNOS, gene-deletion. BMB reports 43: 629-634.